In vitro and in vivo studies have demonstrated that overexpression of DYRK1A leads to increased phosphorylation of Ccnd2 (Table 1), promotes its subsequent proteasomal degradation and thus dysregulation, leading to compromised cardiomyocyte proliferation and finally cardiomyopathy [129]. Here, DYRK1A is linked to cardiomyopathy.